Hui-ju Kao

Hsinchu, TNQ 30068, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Transcriptomic Evidence of Immune-Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma.

Transcriptomic Evidence of Immune-Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma.

Journal: International journal of molecular sciences

Published: March 23, 2026

A Reproducible Sequence-Level Strategy to Enhance Peptide Immunogenicity While Preserving Wild-Type Epitope Recognition.

A Reproducible Sequence-Level Strategy to Enhance Peptide Immunogenicity While Preserving Wild-Type Epitope Recognition.

Journal: Antibodies (Basel, Switzerland)

Published: November 16, 2025

A prognostic 19-gene signature and LBP-mediated immune dysregulation define the tumor microenvironment in poor-prognosis KIRC.

A prognostic 19-gene signature and LBP-mediated immune dysregulation define the tumor microenvironment in poor-prognosis KIRC.

Journal: International journal of medical sciences

Published: September 19, 2025

A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanoma.

A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanoma.

Journal: Molecular medicine (Cambridge, Mass.)

Published: July 21, 2025

iDNS3IP: Identification and Characterization of HCV NS3 Protease Inhibitory Peptides.

iDNS3IP: Identification and Characterization of HCV NS3 Protease Inhibitory Peptides.

Journal: International journal of molecular sciences

Published: May 16, 2025

Synergistic anticancer effects of lipoplex-encapsulated Q7 peptide and doxorubicin against endometrial cancer cells.

Synergistic anticancer effects of lipoplex-encapsulated Q7 peptide and doxorubicin against endometrial cancer cells.

Journal: Scientific reports

Published: March 14, 2025

Integrating In Silico and In Vitro Approaches to Identify Natural Peptides with Selective Cytotoxicity against Cancer Cells.

Integrating In Silico and In Vitro Approaches to Identify Natural Peptides with Selective Cytotoxicity against Cancer Cells.

Journal: International journal of molecular sciences

Published: May 15, 2024

Microbiome analysis of maternal and neonatal microbial communities associated with the different delivery modes based on 16S rRNA gene amplicon sequencing.

Microbiome analysis of maternal and neonatal microbial communities associated with the different delivery modes based on 16S rRNA gene amplicon sequencing.

Journal: Taiwanese journal of obstetrics & gynecology

Published: July 07, 2023

iDVEIP: A computer-aided approach for the prediction of viral entry inhibitory peptides.

iDVEIP: A computer-aided approach for the prediction of viral entry inhibitory peptides.

Journal: Proteomics

Published: June 21, 2023

Anticancer peptide Q7 suppresses the growth and migration of human endometrial cancer by inhibiting DHCR24 expression and modulating the AKT-mediated pathway.

Anticancer peptide Q7 suppresses the growth and migration of human endometrial cancer by inhibiting DHCR24 expression and modulating the AKT-mediated pathway.

Journal: International journal of medical sciences

Published: August 25, 2022

iDVIP: identification and characterization of viral integrase inhibitory peptides.

iDVIP: identification and characterization of viral integrase inhibitory peptides.

Journal: Briefings in bioinformatics

Published: May 26, 2022

Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties.

Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties.

Journal: Scientific reports

Published: November 10, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026